What is Halozyme Therapeutics's net income?

Halozyme Therapeutics (HALO) reported net income of $150.05M in Q1 2026.

How has Halozyme Therapeutics's net income changed year-over-year?

Halozyme Therapeutics's net income increased by 27.1% year-over-year, from $118.1M to $150.05M.

What is the long-term trend for Halozyme Therapeutics's net income?

Over 3 years (2021 to 2024), Halozyme Therapeutics's net income has grown at a 3.3% compound annual growth rate (CAGR), from $402.71M to $444.09M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Halozyme Therapeutics HALO Net Income

Net Income at other companies

West Pharmaceutical ServicesWST

$138.8M+54.6%

BridgeBio PharmaBBIO

-$166.56M+1.8%

Arrowhead ResearchARWR

-$137.57M-137%

AptarGroupATR

$72.77M-7.5%

AbbVieABBV

$697M-45.9%

LQD

Liquidia CorporationLQDA

——

Other financials

Income statement

See full

Revenue$376.7M+42.2%

Gross profit$297.5M+37.4%

Operating income$184.5M+30.4%

Net income$150.0M+27.1%

EPS (diluted)$1.22+31.2%

Balance sheet

See full

Cash & equivalents$312.0M+76.9%

Total debt$2.2B+41.7%

Total equity$219.6M-54.5%

Total assets$2.7B+21.7%

Cash flow

See full

Operating cash flow$180.1M+16.8%

CapEx$3.7M+294%

Free cash flow$176.3M+15.0%

Valuation

See full

Market cap$8.13B-2.9%

Enterprise value$10B+3.0%

P/E13.4×-3.8×

P/S5.4×-2.3×

Profitability

See full

Gross margin82.8%-0.7pp

Operating margin59.3%+9.0pp

Net margin47.9%+6.5pp

FCF margin44.3%-1.5pp

Returns & leverage

See full

Return on equity124.5%+12.7pp

Debt / equity9.9×+6.7×

Current ratio2.8×-5.6×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Halozyme Therapeutics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Halozyme Therapeutics's net income?: Halozyme Therapeutics (HALO) reported net income of $150.05M in Q1 2026.
How has Halozyme Therapeutics's net income changed year-over-year?: Halozyme Therapeutics's net income increased by 27.1% year-over-year, from $118.1M to $150.05M.
What is the long-term trend for Halozyme Therapeutics's net income?: Over 3 years (2021 to 2024), Halozyme Therapeutics's net income has grown at a 3.3% compound annual growth rate (CAGR), from $402.71M to $444.09M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.